Table 4. Cox proportional hazard regression model analysis of gastric cancer patients with stage I and II.
Variables | Univariate analysis |
Multivariate analysis |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Relative risk | 95% CI | P | Relative risk | 95% CI | P | |||||
Gender | ||||||||||
Male vs. female | 0.663 | 0.144-3.047 | 0.597 | |||||||
Age, years | ||||||||||
≤60 vs. >60 | 1.509 | 0.454-5.021 | 0.502 | |||||||
Site | ||||||||||
Non-cardiac cancer vs. cardiac cancer | 2.718 | 0.862-8.576 | 0.088 | |||||||
Lauren type | ||||||||||
Intestinal vs. other types | 0.421 | 0.092-1.931 | 0.266 | |||||||
Differentiation | ||||||||||
Well-Moderatevs. poor | 1.449 | 0.466-4.502 | 0.522 | |||||||
Lymphovascular invasion | ||||||||||
Absent vs. present | 0.770 | 0.168-3.525 | 0.736 | |||||||
Depth of invasion | ||||||||||
T1+T2 vs. T3+T4 | 1.344 | 0.402-4.489 | 0.631 | |||||||
Lymph node metastasis | ||||||||||
Absent vs. present | 0.327 | 0.088-1.212 | 0.094 | 0.274 | 0.073-1.028 | 0.038 | ||||
TNM stage | ||||||||||
I vs. II | 1.758 | 0.385-8.039 | 0.467 | |||||||
LGR5 expression | ||||||||||
Low expression vs. high expression | 3.346 | 1.062-10.544 | 0.039 | 3.971 | 1.242-12.699 | 0.020 |